- The United States health authorities are keeping an eye on the novel COVID-19 variant HV.1.
- Approximately 20% of all COVID-19 cases in the nation are caused by this variant.
- Fever, chills, headache, exhaustion, sore throat, runny or congested nose, nausea, and vomiting are some of the symptoms of HV.1.
The United States health authorities are keeping an eye on the novel COVID-19 variant HV.1, which may eventually displace the current dominant variant, EG.5.
The Centers for Disease Control and Prevention (CDC) report that HV.1 first appeared in the middle of summer, long before the number of cases started to rise sharply in September. Currently, approximately 20% of all COVID-19 cases in the nation are caused by this variant.
Asian stocks
It is imperative to comprehend the novel COVID-19 variant, HV.1, which has undergone numerous mutations since its initial release in December 2021, as winter draws near.
With nearly one in five cases, HV.1 is currently the most common strain in the US. Its growth has been extremely quick; by late July, it had nearly surpassed EG.5 and was up to 0.5%. SARS-CoV-2 will always have new variants, according to infectious disease expert Amesh A. Adalja, M.D., so experts are not concerned about the variant.
Fever, chills, headache, exhaustion, sore throat, runny or congested nose, nausea, and vomiting are some of the symptoms associated with HV.1. Other symptoms include headache, body aches, muscles, and loss of taste or smell.
Since HV.1 is a “grandchild” of the XBB.15 variant, the updated COVID-19 vaccine should protect against it. The current vaccinations may offer a defense against the dangerous illness brought on by HV.1.
